---
category: news
title: "FDA Grants Breakthrough Device Designation To Tempus' HLA-LOH Companion Diagnostic Test"
excerpt: "Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its HLA-L"
publishedDateTime: 2023-08-15T13:30:00Z
originalUrl: "https://www.benzinga.com/pressreleases/23/08/b33858918/fda-grants-breakthrough-device-designation-to-tempus-hla-loh-companion-diagnostic-test"
webUrl: "https://www.benzinga.com/pressreleases/23/08/b33858918/fda-grants-breakthrough-device-designation-to-tempus-hla-loh-companion-diagnostic-test"
ampWebUrl: "https://www.benzinga.com/amp/content/33858918"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/33858918"
type: article
quality: 36
heat: 36
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.benzinga.com/next-assets/images/schema-image-default.png"
    width: 1043
    height: 1043
    isCached: true

secured: "ns2qZ+0IX19Rokn36OJMjWHv7LPEQTLF1OuqAf08Z+dY4NN5AyCFkT/Qlis7SG6Hy7Oi1e96i3YAIRd2pkpr/mZPxHgqjipWCddyRbdsNdQW69pO/nzIm0kzBJb7N2N2gro7FCrLqJvD7DVSmS0nYVAVaxJTIm5H3yefjIO1B7kHvpGcbKGGGn9MdUdCict4h51l1o53Gb77WZBViseoFHtXFt2tM5n0waOpFCHPZlVI4GNK/hNbrCHGz6iJTxt+9Fe1RzBditaynDYuf2YpPvofigU86zjr6eHMk5+Z7bRriwANnVyfPX7K0a4iEusXxuuQJMZJfl41E+3a6eZUX+5wUdi8X1CklS57uHHsdbA=;4L6KZhhiS1ayrOz1/38aqA=="
---

